Wayne Remell Walker
CIK 1428761 · last filed 2026-09-23
Wayne Remell Walker is a corporate insider who has filed 56 SEC Form 4 insider transactions across 10 companies since 2020. The most recent filing, for PBI, was dated Sep 23, 2026. Across all open-market trades the lifetime net is −$36.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.9M across reported positions. 6 SEC filings were submitted jointly with PharmaCyte Biotech, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AYRO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 1720
PHILADELPHIA, PA 19103
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PBI | Director | 5,601 | $15.40 | $86.3K | $0 | 3 | 2026-09-23 |
| POWW | Director | 191,413 | $2.28 | $436.4K | $0 | 1 | 2026-08-19 |
| PMCB | Director | 20,625 | $0.41 | $8.4K | $0 | 5 | 2026-07-17 |
| FABC | Director | — | $1.70 | — | $0 | 1 | 2026-06-18 |
| POWWP | Director | 176,413 | $23.75 | $4.19M | $0 | 14 | 2026-05-19 |
| StableX Technologies, Inc. (SBLX) Delisted | Director | — | $3.10 | — | $0 | 1 | 2025-10-31 |
| Petros Pharmaceuticals, Inc. (PTPI) Delisted | Director | 6,333 | $0.01 | $39 | $0 | 8 | 2025-02-21 |
| StableX Technologies, Inc. (AYRO) Delisted | Director | 6,362 | $7.08 | $45.0K | -$36.4K | 10 | 2024-12-02 |
| WRAP | Director | 134,575 | $1.25 | $168.2K | $0 | 6 | 2023-10-19 |
| WRAP TECHNOLOGIES, INC. (WRTC) Delisted | Director | 10,070 | — | — | $0 | 1 | 2020-01-17 |
Recent Filings
56 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-23 | PBI | Exer (M) | +5,601 | $0 | EDGAR |
| 2026-08-19 | POWW | Grant (A) | +15,000 | $0 | EDGAR |
| 2026-07-17 | PMCB | Other (J) | — | $0 | EDGAR |
| 2026-06-18 | FABC | Grant (A) | — | $0 | EDGAR |
| 2026-06-08 | — | Grant (A) | +375,000 | $0 | |
| 2026-05-19 | POWWP | Grant (A) | +15,000 | $29.1K | EDGAR |
| 2026-05-14 | PBI | Grant (A) | — | $0 | EDGAR |
| 2026-04-02 | PMCB | Grant (A) | — | $0 | EDGAR |
| 2026-02-18 | POWWP | Grant (A) | +15,000 | $0 | EDGAR |
| 2026-01-02 | — | Grant (A) | +500,000 | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.